Buy & Sell Raytheon Technologies Corp (RTX) – Raytheon Technologies Corp Price Today
Aura AI Summary
Key Stats
- $243.74BMarket Cap
- IndustrialsSector
- -17.79%3M Drawdown
- $275.85BEnterprise Value
- 1.53%Dividend Yield
- 66 daysTypical Hold Time
Raytheon Technologies Corp (RTX) is currently valued at a market capitalization of $243.74B, with an enterprise value of $275.85B. Over the past 52 weeks, Raytheon Technologies Corp has traded between a low of $138.52 and a high of $212.16, highlighting its annual price range. Over the past three months, Raytheon Technologies Corp has recorded a drawdown of -17.79%, reflecting recent price volatility. Raytheon Technologies Corp offers a dividend yield of 1.53%, with the most recent dividend of $0.73 paid on 22 May 26. On average, investors hold Raytheon Technologies Corp for approximately 66 days, indicating typical investor behavior on the platform.
About Raytheon Technologies Corp
Raytheon Technologies is a diversified aerospace and defense industrial company formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace manufactures and to the defense market as a prime and subprime contractor.
Most Recent News
Digital Realty launches Malaysia data center operations to boost Southeast Asia's digital and AI infrastructure.
Digital Realty has officially launched its Malaysia operations with a new data center campus in Cyberjaya, aiming to expand its capacity to 32 MW. This development integrates Malaysia into Digital Realty's global network, supporting AI and data-drive...

VCI Global launches Galactic OPC, an AI-native business system integrating smart software and NVIDIA GPU infrastructure.
VCI Global Limited, through its subsidiary V Gallant Limited, announced the launch of Galactic OPC, an AI-native business operating system designed to help entrepreneurs and businesses efficiently build, operate, and scale in an AI-driven economy. Th...

IXICO expands expert team and partners on new Parkinson’s imaging research.
IXICO PLC has strengthened its scientific advisory board by adding three senior specialists in Alzheimer’s and Parkinson’s diseases. The company also launched a new research collaboration with the Paris Brain Institute to improve MRI imaging techniqu...
